Vycor Medical, Inc., a leader in minimally invasive neurosurgical and vision rehabilitation technologies, has reported a substantial increase in its financial results for the three and six months ended June 30, 2025. The company's revenue for the three months reached $496,353, marking a 22% increase compared to the same period in 2024. This growth is attributed to the Vycor Medical division, which saw a 24% rise in revenue, primarily from international markets.
The company's operating profit for the three months stood at $51,146, with a non-GAAP operating profit of $84,481, showcasing significant improvements over the previous year. This financial upturn is supported by new distribution agreements in France and Spain, key markets for Vycor's international expansion strategy.
Technological advancements and clinical validations have also played a crucial role in Vycor's success. The ViewSite™ Brain Access System (VBAS) has been the subject of two new clinical papers, adding to a total of 48 peer-reviewed studies. These studies underscore the clinical benefits of VBAS in brain surgery and neuro-oncology. Additionally, a new study on NovaVision’s NeuroEyeCoach has demonstrated its effectiveness in both home and clinic settings, aligning with global healthcare trends towards digital and remote therapies.
For the six months ended June 30, 2025, Vycor reported a 25% increase in revenue, totaling $932,731. The Vycor Medical division contributed $900,308 to this figure, a 28% increase from 2024. Despite a slight decrease in gross profit margin due to validation and shipping costs, the company's financial health remains robust, with a non-GAAP operating profit of $106,944 for the six-month period.
These financial results highlight Vycor Medical's growing influence in the medical technology sector, particularly in neurosurgery and vision rehabilitation. The company's focus on innovation, coupled with strategic international expansion, positions it as a key player in improving patient outcomes worldwide. For more information on Vycor Medical's technologies, visit https://www.vycormedical.com and https://www.vycorvbas.com.
